Separation Agreements in the Pharmaceuticals Industry

337 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (1 contract)
ACELRX PHARMACEUTICALS INC (2)
Aclaris Therapeutics, Inc. (1)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (1)
Aegerion Pharmaceuticals, Inc. (1)
AEOLUS PHARMACEUTICALS, INC. (3)
AERIE PHARMACEUTICALS INC (2)
AKESIS PHARMACEUTICALS, INC. (2)
Allergan, plc (3)
Altus Pharmaceuticals Inc. (3)
Amag Pharmaceuticals (2)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (1)
ANADYS PHARMACEUTICALS INC (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (3)
APP Pharmaceuticals, Inc. (1)
APRICUS BIOSCIENCES, INC. (2)
Aquestive Therapeutics, Inc. (2)
Assertio Holdings, Inc. (4)
ATAI Life Sciences B.V. (1)
Athira Pharma, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (8)
AVANIR PHARMACEUTICALS, INC. (2)
AYTU BIOSCIENCE, INC (1)
Baudax Bio, Inc. (1)
Bausch Health Companies Inc. (11)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
Boston Therapeutics, Inc. (1)
Cara Therapeutics, Inc. (1)
Cerecor Inc. (4)
CHIASMA, INC (1)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (1)
COGNITION THERAPEUTICS INC (1)
ContraVir Pharmaceuticals, Inc. (1)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (3)
CPEX Pharmaceuticals, Inc. (1)
Cure Pharmaceutical Holding Corp. (1)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (4)
Elanco Animal Health Inc (2)
Eloxx Pharmaceuticals, Inc. (1)
ENCYSIVE PHARMACEUTICALS INC (2)
Endo International plc (4)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (4)
Evolus, Inc. (5)
Exactus, Inc. (1)
EYEGATE PHARMACEUTICALS INC (1)
EYETECH PHARMACEUTICALS INC (1)
Fresenius Kabi Pharmaceuticals Holding, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (1)
Harmony Biosciences Holdings, Inc. (2)
HARVEST HEALTH & RECREATION INC. (1)
Horizon Pharma plc (1)
Hoth Therapeutics, Inc. (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
IMARA Inc. (4)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (6)
Jazz Pharmaceuticals plc (1)
Johnson & Johnson (1)
Kaleido Biosciences, Inc. (1)
KEMPHARM, INC (1)
Landos Biopharma, Inc. (2)
Lannett Company, Inc. (6)
Level Brands, Inc. (4)
Lipocine Inc. (2)
Liquidia Corp (1)
Lyra Therapeutics, Inc. (1)
Mallinckrodt (6)
Merck (16)
MJ Holdings, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (6)
MYnd Analytics, Inc. (3)
Nabriva Therapeutics plc (7)
NEKTAR THERAPEUTICS (9)
Neos Therapeutics, Inc. (1)
Neuralstem, Inc. (3)
NewBridge Global Ventures, Inc. (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (4)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (2)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (5)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (1)
Organon & Co. (1)
Paratek Pharmaceuticals, Inc. (1)
Perrigo (1)
Petros Pharmaceuticals, Inc. (1)
Pfizer (6)
Phathom Pharmaceuticals, Inc. (2)
Phibro Animal Health Corporation (1)
PLx Pharma Inc. (1)
ProPhase Labs, Inc. (1)
Pulmatrix, Inc. (2)
Recro Pharma, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
Revance Therapeutics, Inc. (4)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (1)
Sagent Pharmaceuticals, Inc. (2)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (2)
scPharmaceuticals Inc. (2)
SenesTech, Inc. (4)
Sienna Biopharmaceuticals, Inc. (4)
SIGA TECHNOLOGIES INC (1)
Sonoma Pharmaceuticals, Inc. (6)
Sucampo Pharmaceuticals, Inc. (4)
SYNERGY PHARMACEUTICALS, INC. (3)
Tarsus Pharmaceuticals, Inc. (1)
Terra Tech Corp. (6)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
Textmunication Holdings, Inc. (2)
The Medicines Company (1)
Theravance Biopharma, Inc. (2)
Tilray, Inc. (4)
TILT Holdings Inc. (2)
Upjohn Inc (6)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Vallon Pharmaceuticals, Inc. (1)
VIA Pharmaceuticals, Inc. (2)
Virpax Pharmaceuticals, Inc. (1)
Vitality Biopharma, Inc. (2)
XERIS PHARMACEUTICALS INC (1)
Zoetis (3)
Zomedica Pharmaceuticals Corp. (4)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Separation Agreement, dated May 4, 2023, by and between Registrant and Leonard Greenstein (Tarsus Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
Employment Separation and Release Agreement effective as of June 19, 2023 by and between Nektar Therapeutics and Jillian B. Thomsen (NEKTAR THERAPEUTICS, Filed With SEC on August 9, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Nabriva Therapeutics plc, Filed With SEC on July 7, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan (Nabriva Therapeutics plc, Filed With SEC on July 7, 2023)
Separation Agreement dated June 28, 2023 by and between TILT Holdings Inc. and Dana Arvidson (TILT Holdings Inc., Filed With SEC on July 5, 2023)
Separation and Mutual Release Agreement (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)
Separation agreement, dated June 18, 2023 by and between Virpax Pharmaceuticals, Inc. and Christopher Chipman (Virpax Pharmaceuticals, Inc., Filed With SEC on June 21, 2023)
Separation Agreement and Release between John Temperato and 9 Meters Biopharma, Inc., dated May 29, 2023 (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on May 30, 2023)
Separation Agreement, dated March 31, 2023, by and between Detlef Albrecht and Satsuma Pharmaceuticals, Inc (Satsuma Pharmaceuticals, Inc., Filed With SEC on May 11, 2023)
Separation Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc (Johnson & Johnson, Filed With SEC on May 8, 2023)
Separation Agreement dated April 21, 2023 by and between TILT Holdings Inc. and Gary F. Santo, Jr (TILT Holdings Inc., Filed With SEC on April 25, 2023)
Separation Agreement between SenesTech, Inc. and Nicole Williams dated April 21, 2023 (SenesTech, Inc., Filed With SEC on April 24, 2023)
Separation Agreement, dated April 21, 2023, by and between GRI Bio, Inc. and David Baker (Vallon Pharmaceuticals, Inc., Filed With SEC on April 21, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Nabriva Therapeutics plc, Filed With SEC on April 17, 2023)
Separation Agreement and General Release, dated April 14, 2023, by and between John Kozlowski and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on April 14, 2023)
Separation Agreement, dated March 16, 2023, between Zomedica Inc. and Ann Marie Cotter (Zomedica Pharmaceuticals Corp., Filed With SEC on March 17, 2023)
Rahul Ballal Separation Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
Michael Gray Separation Agreement, dated February 23, 2023 (IMARA Inc., Filed With SEC on March 1, 2023)
Separation Agreement with Michael Goettler, dated February 24, 2023 (Upjohn Inc, Filed With SEC on February 27, 2023)
Merck & Co., Inc. U.S. Separation Benefits Plan (amended and restated as of January 1, 2019) as further amended by Amendments 2019-1 (as of December 19, 2019), 2020-1 (as of... (Merck, Filed With SEC on February 24, 2023)
Separation Agreement and General Release, dated as of December 9, 2022, by and between the Registrant and Frank Ruffo (Aclaris Therapeutics, Inc., Filed With SEC on February 23, 2023)
Form of Separation Agreement and General Release (OptiNose, Inc., Filed With SEC on January 31, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder (Nabriva Therapeutics plc, Filed With SEC on January 20, 2023)
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Steven Gelone (Nabriva Therapeutics plc, Filed With SEC on January 20, 2023)
Separation Agreement between SenesTech, Inc. and Kenneth Siegel dated December 29, 2022 (SenesTech, Inc., Filed With SEC on January 5, 2023)
Separation Agreement and General Release by and between the Company and Stefanie Johns dated December 9, 2022 (Hoth Therapeutics, Inc., Filed With SEC on December 13, 2022)
Separation Agreement and Release with former Chief Executive Officer (Neuralstem, Inc., Filed With SEC on October 14, 2022)
Separation Agreement and Release, dated October 4, 2022, by and between ProPhase Labs, Inc. and Bill White (ProPhase Labs, Inc., Filed With SEC on October 7, 2022)
Separation and Release of Claims Agreement by and between the Company and Jyoti Chauhan, dated May 4, 2022 (Landos Biopharma, Inc., Filed With SEC on August 11, 2022)
Separation Agreement, dated as of June 1, 2022, by and between Bausch Health Companies Inc. and Robert Spurr (Bausch Health Companies Inc., Filed With SEC on August 9, 2022)
Employment Transition, Separation and Consultation Agreement, dated as of June 29, 2022, by and between Nektar Therapeutics and John Northcott (NEKTAR THERAPEUTICS, Filed With SEC on August 5, 2022)
Separation Agreement and General Release of Claims, dated May 3, 2022, by and between Evolus, Inc. and Lauren Silvernail (Evolus, Inc., Filed With SEC on August 2, 2022)
Transition and Separation Agreement and Release of Claims, dated April 5, 2022, by and between the Registrant and Anthony Guzzo (Phathom Pharmaceuticals, Inc., Filed With SEC on August 2, 2022)
Separation Agreement dated July 12, 2022, by and among the Company, Daedalus Ecosciences, Range Environmental Resources, Range Natural Resources, Joshua Justice and Christine... (Vitality Biopharma, Inc., Filed With SEC on July 15, 2022)
Transition and Separation Agreement, dated June 15, 2022, by and among ATAI Life Sciences US, Inc., ATAI Life Sciences N.V. and Greg Weaver (ATAI Life Sciences B.V., Filed With SEC on June 17, 2022)
Separation Agreement dated June 11, 2022 (Level Brands, Inc., Filed With SEC on June 14, 2022)
Separation Agreement dated June 11, 2022 (Level Brands, Inc., Filed With SEC on June 13, 2022)
Separation Agreement and Release dated as of May 18, 2022 (Adamis Pharmaceuticals Corp, Filed With SEC on May 19, 2022)
Separation Agreement, dated May 17, 2022, between Aquestive Therapeutics, Inc. and Keith J. Kendall (Aquestive Therapeutics, Inc., Filed With SEC on May 17, 2022)
Separation Agreement and General Release by and among the Company, iAnthus Capital Management, LLC and Randy Maslow dated April 28, 2022 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on May 12, 2022)